DMKJ
MREO

David M. Knott Jr’s Mereo BioPharma MREO Stock Holding History

David M. Knott Jr’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.1K Hold
300,337
– – 0.06% 65
2025
Q4 		$125K Hold
300,337
– – 0.06% 64
2025
Q3 		$619K Sell
300,337
-19,000
-6% -$35K 0.26% 47
2025
Q2 		$865K Hold
319,337
– – 0.39% 35
2025
Q1 		$719K Sell
319,337
-11,663
-4% -$33K 0.34% 36
2024
Q4 		$1.16M Hold
331,000
– – 0.42% 28
2024
Q3 		$1.36M Buy
331,000
+95,000
+40% +$393K 0.48% 32
2024
Q2 		$850K Buy
236,000
+206,000
+687% +$667K 0.34% 39
2024
Q1 		$99K Buy
+30,000
New +$102K 0.04% 72

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return